RACHEL MAXEY: Open Payments
NPI 1679224125 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,281 in 96 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,061 · 2025 $2,281
Food & beverage: $2,188Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $385 |
| Dendreon Pharmaceuticals LLC | 9 | $380 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $269 |
| TOLMAR, INC. | 6 | $205 |
| PFIZER INC. | 9 | $187 |
| Merck Sharp & Dohme LLC | 7 | $154 |
| Astellas Pharma US Inc | 5 | $98 |
| pharmaand GmbH | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
Products named: ERLEADA, PROVENGE, Nubeqa, XTANDI, Rubraca, ELIGARD, ORGOVYX, Padcev.
Industry payments across AL — which companies pay providers there.
